Comparison of the ability of adenosine kinase inhibitors and adenosine receptor agonists to attenuate thermal hyperalgesia and reduce motor performance in rats

Pharmacology Biochemistry and Behavior

Volumn 73, Issue 3, 2002, Pages 573-581

  Jarvis, Michael F ^a   Mikusa, Joe ^a   Chu, Katharine L ^a   Wismer, Carol T ^a   Honore, Prisca ^a   Kowaluk, Elizabeth A ^a   McGaraughty, Steve ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Adenosine; Adenosine kinase; Analgesia; Hyperalgesia; Nociception

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 3,7 DIMETHYL 1 PROPARGYLXANTHINE; 5' DEOXY 5 IODOTUBERCIDIN; 6 N CYCLOPENTYLADENOSINE; A 13474; A 134974; A 286501; ABT 702; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE KINASE INHIBITOR; ADENOSINE RECEPTOR STIMULATING AGENT; CARRAGEENAN; CYCLOPENTYLTHEOPHYLLINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; HYPERALGESIA; MALE; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; TASK PERFORMANCE;

ANIMALIA;

EID: 0036345575     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(02)00840-7     Document Type: Article

References (52)

1. The control of the metabolism and the hormonal role of adenosine
2. Anti-inflammatory effects of ABT-702, a novel adenosine kinase inhibitor, in rat adjuvant arthritis
3. Adenosine-containing neurons in the brain localized by immuno-cytochemistry
4. Site and event specific increase of striatal adenosine release by adenosine kinase inhibition in rats
5. 2 adenosine receptors in the rat spinal cord
6. Halogenated pyrrolopyrimidine analogues of adenosine from marine organisms: Pharmacological activities and potent inhibition of adenosine kinase
7. Complex role of peripheral adenosine in the genesis of the response to subcutaneous formalin in the rat
8. Consequences of activation and adenosine mediated inhibition of granulocytes during myocardial ischemia
9. Anti-inflammatory effects of adenosine kinase inhibitors in acute and chronic inflammation
10. 3H]nitrobenzylthioinosine binding sites in rat spinal cord and primary afferent neurons
11. Distribution of adenosine deaminase in rat brain and spinal cord
12. Adenosine kinase inhibitors augument release of adenosine from spinal cord slices
13. Systemic adenosine infusions alleviated neuropathic pain
14. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
15. Evaluation of adenosine agonists as potential analgesics
16. Characterization of the antinociceptive effects of some adenosine analogues in the rat
17. Characterization of P1 (adenosine) purinoceptors
18. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d] pyrimidine), a novel orally effective adenosine kinase inhibitor analgesic with anti-inflammatory properties: I. In vitro characterization
19. Analgesic and anti-inflammatory effects of A-286501, a novel orally active adenosine kinase inhibitor
20. Spinally mediated antinociception is induced in mice by an adenosine kinase, but not an adenosine deaminase inhibitor
21. Therapeutic potential of adenosine kinase inhibitors
22. Characterization of the effects of adenosine kinase inhibitors on acute thermal nociception in mice
23. ABT-702, (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d] pyridine), a novel orally effective adenosine kinase (ak) inhibitor with analgesic and anti-inflammatory properties: II. Antinociceptive and antiinflammatory effects in rat models of persistent, inflammatory, and neuropathic pain
24. Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain
25. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists
26. Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d] pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitor
27. Potentiation of formalin-evoked adenosine release by an adenosine kinase inhibitor and an adenosine deaminase inhibitor in the rat hind paw: A microdialysis study
28. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction
29. Effects of A-134974, a novel adenosine kinase inhibitor, on carrageenan-induced inflammatory hyperalgesia and locomotor activity in rats: Evaluation of the sites of action
30. Recent developments in the discovery of novel adenosine kinase inhibitors: Mechanism of action and therapeutic potential
31. Turnover of adenosine in plasma of human and dog blood
32. Acadesine: Prototype adenosine regulating agent for treating myocardial ischemia-reperfusion injury
33. Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices
34. 2 smooth muscle cells
35. Antinociception by adenosine analogs and an adenosine kinase inhibitor: Dependence on formalin concentration
36. Antinociception by adenosine analogs and inhibition of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat
37. The roles of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neurones in the anaesthetized rat
38. Purines and nociception
39. Purines in pain management
40. Classification of adenosine receptors mediating antinociception in the rat spinal cord
41. 3,7-Dimethyl-1-propargylxanthine: A potent and selective in vivo antagonist of adenosine analogs
42. Adenosine and pain relief: A clinical overview
43. Antinociceptive effect of perioperative adenosine in hysterectomy
44. Adenosine for pain control
45. The effect of ABT-702, a novel adenosine kinase inhibitor, on the responses of spinal neurones following carrageenan inflammation and peripheral nerve injury
46. Direct cutaneous hyperalgesia induced by adenosine
47. The effect of GP683, an adenosine kinase inhibitor, on the desflurane anesthetic requirement in dogs
48. Potentiation of excitatory amino acid-evoked adenosine release from rat cortex by inhibitors of adenosine kinase and adenosine deaminase and by acadesine
49. Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy
50. Purinergic and pyrimidinergic receptors as potential drug targets
51. A-134974, a novel adenosine kinase inhibitor, relieves tactile allodynia via spinal sites of action in peripheral nerve injured rats